Access cutting-edge alopecia areata treatment through this clinical trial at a research site in Encinitas. Study-provided care at no cost to qualified participants.
Access alopecia areata specialists in Encinitas at no cost
This study follows strict safety protocols and ethical guidelines
All study-related alopecia areata treatment provided free
The main purpose of this study is to determine the efficacy and safety of baricitinib for the treatment of severe or very severe alopecia areata (hair loss) in children from 6 years to less than 18 years of age. The study is divided into 4 periods, a 5-week Screening period, a 36-week Double-Blind Treatment Period, an approximately 2-year Long-term Extension Period, and a 4-week Post-treatment Follow-up period.
Sponsor: Eli Lilly and Company
Check if you qualify for this alopecia areata clinical trial in Encinitas, CA
If you're searching for alopecia areata treatment options in Encinitas, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Encinitas research site is actively enrolling participants for this clinical trial. You'll receive care from experienced alopecia areata specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.